home / stock / ptgx / ptgx short
Short Information | Protagonist Therapeutics Inc. (NASDAQ:PTGX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,779,170 |
Total Actual Volume | 32,222,695 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 138,959 |
Average Short Percentage | 14.03% |
Is there a PTGX Short Squeeze or Breakout about to happen?
See the PTGX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $34.14 | $33.72 | $34.57 | $33.21 | 777,794 | 148,436 | 19.08% |
07-03-2024 | $34.5 | $34.5 | $34.95 | $34.11 | 645,832 | 83,428 | 12.92% |
07-02-2024 | $35.61 | $34.59 | $35.9 | $34.31 | 12,663,346 | 504,110 | 3.98% |
07-01-2024 | $34.76 | $35.2 | $35.82 | $34.65 | 1,736,188 | 228,753 | 13.18% |
06-28-2024 | $35.46 | $34.65 | $35.49 | $33.38 | 4,436,237 | 305,456 | 6.89% |
06-27-2024 | $31.81 | $31.88 | $32.105 | $31.34 | 449,793 | 107,779 | 23.96% |
06-26-2024 | $31.47 | $31.76 | $32.1 | $30.6725 | 543,684 | 90,480 | 16.64% |
06-25-2024 | $31.95 | $31.71 | $32.56 | $31.42 | 378,303 | 56,505 | 14.94% |
06-24-2024 | $32.69 | $32.01 | $32.95 | $31.93 | 305,129 | 49,968 | 16.38% |
06-21-2024 | $31.48 | $32.26 | $33.39 | $31.39 | 2,736,655 | 89,894 | 3.28% |
06-20-2024 | $32.45 | $31.43 | $32.67 | $31.22 | 581,936 | 96,626 | 16.6% |
06-18-2024 | $32.48 | $32.59 | $33.14 | $31.76 | 732,059 | 94,835 | 12.95% |
06-17-2024 | $33.3 | $32.47 | $33.68 | $32.29 | 772,555 | 84,452 | 10.93% |
06-14-2024 | $33.93 | $33.39 | $34 | $33.04 | 442,289 | 90,647 | 20.49% |
06-13-2024 | $33.95 | $34.35 | $35.33 | $33.23 | 477,320 | 74,337 | 15.57% |
06-12-2024 | $35.34 | $33.97 | $35.96 | $33.39 | 436,050 | 59,411 | 13.62% |
06-11-2024 | $32.74 | $33.95 | $34.25 | $32.74 | 1,002,262 | 91,657 | 9.15% |
06-10-2024 | $35.25 | $33.17 | $35.25 | $32.59 | 1,019,641 | 169,203 | 16.59% |
06-07-2024 | $33.72 | $34.8 | $35.55 | $33.67 | 1,127,949 | 216,040 | 19.15% |
06-06-2024 | $33.97 | $34.02 | $34.46 | $33.37 | 957,673 | 137,153 | 14.32% |
News, Short Squeeze, Breakout and More Instantly...
Protagonist Therapeutics Inc. Company Name:
PTGX Stock Symbol:
NASDAQ Market:
Protagonist Therapeutics Inc. Website:
Protagonist Therapeutics Set to Join S&P SmallCap 600 Protagonist Therapeutics Set to Join S&P SmallCap 600 PR Newswire NEW YORK , June 27, 2024 /PRNewswire/ -- Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in ...
Long term follow-up from REVIVE Phase 2 study up to 3 years shows durable hematocrit (Hct) control (< 45%), decreased phlebotomy use, long-term tolerability, and no new safety signals in patients with polycythemia vera Patients receiving rusfertide in the open-label extension of the REVIV...